Reversibility of Apixaban Anticoagulation with a Four‐Factor Prothrombin Complex Concentrate in Healthy Volunteers

It was hypothesized that the four‐factor prothrombin complex concentrate (4F‐PCC) Kcentra 25 unit/kg would reverse impairment of thrombin generation in healthy volunteers dosed with apixaban to steady state. In this randomized, two‐period crossover, assessor‐blinded trial, 12 healthy subjects receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagalla, S, Thomson, L, Oppong, Y, Bachman, B, Chervoneva, I, Kraft, WK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351332/
https://www.ncbi.nlm.nih.gov/pubmed/27170068
http://dx.doi.org/10.1111/cts.12398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351332/
https://www.ncbi.nlm.nih.gov/pubmed/27170068
http://dx.doi.org/10.1111/cts.12398

Ejemplares similares